Asieris Pharmaceuticals Revenue and Competitors

Pudong,

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Asieris Pharmaceuticals's estimated annual revenue is currently $14.1M per year.(i)
  • Asieris Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • Asieris Pharmaceuticals has 70 Employees.(i)
  • Asieris Pharmaceuticals grew their employee count by 8% last year.

Asieris Pharmaceuticals's People

NameTitleEmail/Phone
1
Founder, President and CEOReveal Email/Phone
2
Chief Operating OfficerReveal Email/Phone
3
N/AReveal Email/Phone
4
Research AssociateReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is Asieris Pharmaceuticals?

Asieris Pharmaceuticals, founded in March 2010 in China Medical City in Jiangsu Taizhou, with its R&D Center located in Shanghai, is the only China-based, globally oriented company specializing in the development and commercialization of new drugs for the treatment of genitourinary tumors and related diseases. Asieris Pharmaceuticals is dedicated to becoming the most innovative, influential, respectable, and trustworthy pharmaceutical company in our areas of focus. We create global values of our proprietary first-in-class new drugs with breakthrough potentials. Meanwhile, we in-license late-stage or marketed new drugs from overseas for the Chinese market, in order to enhance our product pipeline and allow us quickly establish leadership in the China market.

keywords:N/A

N/A

Total Funding

70

Number of Employees

$14.1M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Asieris Pharmaceuticals News

2022-04-17 - The Worldwide Genitourinary Drugs Industry is Expected to Reach ...

Abbott; Allergan; Antares Pharma; Asieris Pharmaceuticals; Astellas Pharma Inc; AstraZeneca; Bayer AG; Bristol-Myers Squibb Co.

2022-04-13 - Asieris Pharmaceuticals Announces 2021 Annual Report: Steady ...

Asieris Pharmaceuticals is becoming a leading global pharmaceutical company in its areas of focus with combined capabilities in R&D,...

2022-04-06 - Difficult-to-treat inflammatory bowel disease: results from a global ...

VJ has received consulting and advisory board fees from AbbVie, Alimentiv (formerly Robarts Clinical Trials), Arena Pharmaceuticals, Asahi Kasei Pharma, Asieris...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$47.4M3063%N/A
#2
$251.7M12842%$315M